CLINICAL_TRIALS
trial_result
· 2023-09-14
Clinical Trial Update: Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum [Phase 2]
Summary
A Phase 2 exploratory trial of IFX-1 in patients with pyoderma gangrenosum has completed, with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: InflaRx GmbH | Conditions: Pyoderma Gangrenosum | Phase 2 | Status: COMPLETED | Results posted: 2023-09-14